Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles

被引:178
作者
Cole, Adam J. [1 ]
David, Allan E. [1 ,3 ]
Wang, Jianxin [1 ,4 ]
Galban, Craig J. [2 ]
Yang, Victor C. [1 ,5 ]
机构
[1] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiol, Ctr Mol Imaging, Sch Med, Ann Arbor, MI 48109 USA
[3] Ind Sci & Technol Network Inc, York, PA 17404 USA
[4] Fudan Univ, Dept Pharmaceut, Sch Pharm, Shanghai 201203, Peoples R China
[5] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Modern Drug Delivery & High Effic, Tianjin 300070, Peoples R China
基金
美国国家卫生研究院;
关键词
Magnetic nanoparticles; Magnetic targeting; Polyethylene glycol (PEG); Pharmacokinetics; Drug delivery; Brain tumor; DRUG-DELIVERY; THERAPY; GLIOMA; CHEMOTHERAPY; MRI;
D O I
10.1016/j.biomaterials.2011.05.024
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Magnetic iron oxide nanoparticles (MNPs) have been studied to circumvent the limitations of status-quo brain tumor therapy and can be targeted by applying an external magnetic field to lesions. To address the pharmacokinetic shortcomings of MNPs that can limit targeting efficiency, we recently reported a long-circulating polyethylene glycol modified, cross-linked starch MNP (PEG-MNP) suitable for magnetic targeting. Using a rat model, this work explores the biodistribution patterns of PEG-MNPs in organs of elimination (liver, spleen, lung, and kidney) and shows proof-of-concept that enhanced magnetic brain tumor targeting can be achieved due to the relatively long circulation lifetime of the nanoparticles. Reductions in liver (similar to 12-fold) and spleen (similar to 2.5-fold) PEG-MNP concentrations at 1 h compared to parent starch-coated MNPs (D) confirm plasma pharmacokinetics observed previously. While liver concentrations of PEG-MNPs remained considerably lower than those observed for D at 1 h through 60 h, spleen values continue to increase and are markedly higher at later time points a trend also observed with histology. Limited to no distribution of PEG-MNPs was visualized in lung or kidney throughout the 60 h course evaluated. Enhanced, selective magnetic brain tumor targeting (t = 1 h) of PEG-MNPs (12 mg Fe/kg) was confirmed in 9L-glioma tumors, with up to 1.0% injected dose/g tissue nanoparticle delivery achieved - a 15-fold improvement over targeted D (0.07% injected dose/g tissue). MRI and histological analyses visually confirmed enhanced targeting and also suggest a limited contribution of passive mechanisms to tissue retention of nanoparticles. Our results are exciting and justify both further development of PEG-MNP as a drug delivery platform and concurrent optimization of the magnetic brain tumor targeting strategy utilized. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6291 / 6301
页数:11
相关论文
共 30 条
  • [1] Functional Delivery of siRNA in Mice Using Dendriworms
    Agrawal, Amit
    Min, Dal-Hee
    Singh, Neetu
    Zhu, Haihao
    Birjiniuk, Alona
    von Maltzahn, Geoffrey
    Harris, Todd J.
    Xing, Deyin
    Woolfenden, Stephen D.
    Sharp, Phillip A.
    Charest, Alain
    Bhatia, Sangeeta
    [J]. ACS NANO, 2009, 3 (09) : 2495 - 2504
  • [2] Bowdler A., 2002, The complete spleen. Structure
  • [3] Carson FL., 1997, HISTOTECHNOLOGY SELF, VSecond
  • [4] Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors
    Chertok, Beata
    Moffat, Bradford A.
    David, Allan E.
    Yu, Faquan
    Bergemann, Christian
    Ross, Brian D.
    Yang, Victor C.
    [J]. BIOMATERIALS, 2008, 29 (04) : 487 - 496
  • [5] Glioma selectivity of magnetically targeted nanoparticles: A role of abnormal tumor hydrodynamics
    Chertok, Beata
    David, Allan E.
    Huang, Yongzhuo
    Yang, Victor C.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2007, 122 (03) : 315 - 323
  • [6] Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration
    Chertok, Beata
    David, Allan E.
    Yang, Victor C.
    [J]. BIOMATERIALS, 2010, 31 (24) : 6317 - 6324
  • [7] Comparison of Electron Spin Resonance Spectroscopy and Inductively-Coupled Plasma Optical Emission Spectroscopy for Biodistribution Analysis of Iron-Oxide Nanoparticles
    Chertok, Beata
    Cole, Adam J.
    David, Allan E.
    Yang, Victor C.
    [J]. MOLECULAR PHARMACEUTICS, 2010, 7 (02) : 375 - 385
  • [8] Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking
    Chertok, Beata
    David, Allan E.
    Moffat, Bradford A.
    Yang, Victor C.
    [J]. BIOMATERIALS, 2009, 30 (35) : 6780 - 6787
  • [9] Cancer theranostics: the rise of targeted magnetic nanoparticles
    Cole, Adam J.
    Yang, Victor C.
    David, Allan E.
    [J]. TRENDS IN BIOTECHNOLOGY, 2011, 29 (07) : 323 - 332
  • [10] Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting
    Cole, Adam J.
    David, Allan E.
    Wang, Jianxin
    Galban, Craig J.
    Hill, Hannah L.
    Yang, Victor C.
    [J]. BIOMATERIALS, 2011, 32 (08) : 2183 - 2193